Plasmonic Graphene–Gold Nanostar Heterojunction for Red-Light Photoelectrochemical Immunosensing of C-Reactive Protein
ACS Sensors · 2025
DOI: 10.1021/acssensors.4c03652 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Sensors, 2025. Verfasst von Yeison Monsalve und 2 weiteren Autor:innen. Beteiligte Einrichtung: Max Planck Tandem Group in Nanobioengineering, Institute of Chemistry, Faculty of Natural and Exact Sciences, University of Antioquia, Complejo Ruta …. Hauptthemen laut MEDLINE: C-Reactive Protein, Gold, Graphite, Electrochemical Techniques. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 75 Literaturangaben. Gefördert von: Universidad de Antioquia, Max-Planck-Gesellschaft, Ministerio de Ciencia, Tecnolog?a e Innovaci?n.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Max Planck Tandem Group in Nanobioengineering, Institute of Chemistry, Faculty of Natural and Exact Sciences, University of Antioquia, Complejo Ruta N, Calle 67 No. 52-20, Medellín 050010, Colombia.
ORCID-Profile: Andrés F Cruz-Pacheco, Jahir Orozco
Förderung
- Universidad de Antioquia
- Max-Planck-Gesellschaft
- Ministerio de Ciencia, Tecnolog?a e Innovaci?n
Zitieren
APA
Monsalve, Y., Cruz-Pacheco, A. F., & Orozco, J. (2025). Plasmonic Graphene–Gold Nanostar Heterojunction for Red-Light Photoelectrochemical Immunosensing of C-Reactive Protein. ACS Sensors. https://doi.org/10.1021/acssensors.4c03652
Vancouver
Monsalve Y, Cruz-Pacheco AF, Orozco J. Plasmonic Graphene–Gold Nanostar Heterojunction for Red-Light Photoelectrochemical Immunosensing of C-Reactive Protein. ACS Sensors. 2025. doi:10.1021/acssensors.4c03652
BibTeX
@article{Monsalve2025,
author = {Monsalve, Yeison and Cruz-Pacheco, Andrés F and Orozco, Jahir},
title = {Plasmonic Graphene–Gold Nanostar Heterojunction for Red-Light Photoelectrochemical Immunosensing of C-Reactive Protein},
journal = {ACS Sensors},
year = {2025},
doi = {10.1021/acssensors.4c03652}
}
EUVIMED